Vivos Therapeutics (OTCMKTS:RDGL) Stock Attempts To Rebound: Now What?
Medical technology company Vivos Therapeutics (OTCMKTS:RDGL), on September 20, 2021, announced that the US Food and Drug Administration had allowed market clearance to Vivos’ mmRNA device to treat mild to moderate sleep-related breathing as well as snoring in adults. Vivos… Continue Reading